The estimated Net Worth of Michael B Mason is at least $31.5 Million dollars as of 1 February 2023. Michael Mason owns over 6,690 units of Lilly(Eli) & Co stock worth over $31,490,754 and over the last 5 years he sold LLY stock worth over $0. In addition, he makes $0 as Senior Vice President and President und Lilly Diabetes at Lilly(Eli) & Co.
Michael has made over 2 trades of the Lilly(Eli) & Co stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 6,690 units of LLY stock worth $6,160,754 on 1 February 2023.
The largest trade he's ever made was exercising 6,690 units of Lilly(Eli) & Co stock on 1 February 2023 worth over $6,160,754. On average, Michael trades about 2,156 units every 147 days since 2020. As of 1 February 2023 he still owns at least 34,196 units of Lilly(Eli) & Co stock.
You can see the complete history of Michael Mason stock trades at the bottom of the page.
Michael Mason is the Senior Vice President and President, Lilly Diabetes at Lilly(Eli) & Co.
Michael Mason is 53, he's been the Senior Vice President and President und Lilly Diabetes of Lilly(Eli) & Co since 2020. There are 16 older and 11 younger executives at Lilly(Eli) & Co. The oldest executive at Lilly(Eli) & Co is Kathi Seifert, 71, who is the Independent Director.
Michael's mailing address filed with the SEC is Eli Lilly and Company Corporate Center, Indianapolis, Marion County, Indiana, United States.
Over the last 20 years, insiders at Lilly(Eli) & Co have traded over $29,994,829,903 worth of Lilly(Eli) & Co stock and bought 73,808 units worth $5,778,435 . The most active insiders traders include Endowment Inc Lilly, R David Hoover und Lorenzo Tallarigo. On average, Lilly(Eli) & Co executives and independent directors trade stock every 7 days with the average trade being worth of $55,447,708. The most recent stock trade was executed by Endowment Inc Lilly on 3 September 2024, trading 24,084 units of LLY stock currently worth $23,281,762.
Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by, and named after, Colonel Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War.
Lilly(Eli) & Co executives and other stock owners filed with the SEC include: